Unjha Formulations Limited Announces Board Meeting for FY26 Financial Results

1 min read     Updated on 22 Apr 2026, 04:53 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Unjha Formulations Limited has intimated the Bombay Stock Exchange about a scheduled board meeting to be held on 18 May 2026. The meeting, convened under Regulation 29(1)(a) of SEBI Listing Obligation and Disclosure Requirement Regulations, 2015, will consider the audited financial results for the quarter and year ended 31 March 2026 of the financial year 2024-25. Additionally, the board will discuss the appointment of a secretarial auditor for FY 2025-26. The meeting is scheduled to take place at 13.30 p.m. at the company's registered office in Sidhpur, Gujarat.

powered bylight_fuzz_icon
38402604

*this image is generated using AI for illustrative purposes only.

Unjha Formulations Limited has informed the Bombay Stock Exchange about an upcoming board meeting scheduled to be held on Monday, 18 May 2026. The meeting will be conducted at 13.30 p.m. at the company's registered office located at Khali Char Rasta, State Highway, Sidhpur - 384151. The intimation has been made in accordance with Regulation No. 29(1)(a) of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015.

Agenda for the Board Meeting

The board has outlined two key items on the agenda for discussion and consideration during the meeting:

  • To consider and take on record the Audited Financial Results of the company for the Quarter Ended as on 31.03.2026 and Year Ended as on 31.03.2026 of the Financial Year 2024-25
  • To appoint a Secretarial Auditor for FY 2025-26 of the Company

Meeting Details

Particulars Details
Date of Meeting 18 May 2026
Time 13.30 p.m.
Venue Registered Office, Khali Char Rasta, State Highway, Sidhpur - 384151
Regulation Reference Regulation 29(1)(a) of SEBI LODR Regulations, 2015

The communication, dated 21 April 2026, was addressed to the Manager (Listing) at the Bombay Stock Exchange Ltd. The intimation was signed by Krutiben M. Patel, Managing Director of the company, bearing DIN 01866427. Unjha Formulations Limited is registered with CIN NO. L99999GJ1994PLC022932 and GSTIN/UIN 24AAAACU1998G1Z7.

Historical Stock Returns for Unjha Formulations

1 Day5 Days1 Month6 Months1 Year5 Years
-4.44%-2.29%-4.44%-19.27%-14.99%+132.79%

What factors might influence Unjha Formulations' financial performance in FY 2025-26 given the current pharmaceutical market conditions?

How could the appointment of a new secretarial auditor impact the company's governance practices and compliance framework going forward?

What strategic initiatives might Unjha Formulations announce alongside their annual results to drive growth in FY 2026-27?

Unjha Formulations Limited Files SEBI Compliance Certificate for Q4 FY26

1 min read     Updated on 10 Apr 2026, 07:39 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Unjha Formulations Limited submitted its mandatory SEBI compliance certificate to BSE for the quarter and year ended March 31, 2026, under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate, confirmed by transfer agent MUFG Intime India Private Limited, validates proper dematerialization processes and regulatory adherence. Managing Director Krutiben M. Patel authorized the April 10, 2026 submission, ensuring compliance with securities market regulations for the company trading under BSE code 531362.

powered bylight_fuzz_icon
37375754

*this image is generated using AI for illustrative purposes only.

Unjha Formulations Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling mandatory regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The pharmaceutical company submitted the certificate for the quarter and year ended March 31, 2026, demonstrating adherence to securities market regulations.

Regulatory Compliance Submission

The company submitted its certificate under Regulation 74(5) of SEBI regulations on April 10, 2026, through a formal communication to BSE's Listing Department. Managing Director Krutiben M. Patel signed the submission letter, ensuring proper authorization of the regulatory filing.

Filing Details: Information
Submission Date: April 10, 2026
Reporting Period: Quarter and Year ended March 31, 2026
BSE Security Code: 531362
Signatory: Krutiben M. Patel, Managing Director
DIN: 01866427

Transfer Agent Confirmation

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, served as the company's registrar and transfer agent for the reporting period. The transfer agent issued a confirmation certificate dated April 1, 2026, validating the proper handling of dematerialization processes.

The transfer agent confirmed that all securities received from depository participants for dematerialization during the quarter ended March 31, 2026, were processed according to regulatory requirements. The confirmation covered several key compliance areas:

  • Securities received for dematerialization were confirmed or rejected to depositories within prescribed timelines
  • Security certificates were properly mutilated and cancelled after verification
  • Depository names were substituted in the register of members as registered owners
  • All securities remained listed on stock exchanges where previously issued securities are traded

Corporate Information

The company operates from its registered office at Khali Char Rasta, State Highway, Sidhpur, Mahesana, with PIN code 384151. Ashok Shetty, Senior Vice President of Corporate Registry at MUFG Intime India Private Limited, signed the transfer agent's confirmation certificate.

Regulatory Framework

Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 mandates listed companies to obtain and submit confirmation certificates from their registrar and transfer agents. This requirement ensures transparency in dematerialization processes and maintains investor confidence in securities market operations.

The filing demonstrates Unjha Formulations Limited's commitment to regulatory compliance and proper corporate governance practices in securities market operations.

Historical Stock Returns for Unjha Formulations

1 Day5 Days1 Month6 Months1 Year5 Years
-4.44%-2.29%-4.44%-19.27%-14.99%+132.79%

How might Unjha Formulations' consistent regulatory compliance impact its eligibility for institutional investor participation and ESG fund inclusions?

What strategic initiatives could the company pursue in FY2027 following its successful completion of regulatory requirements for the previous fiscal year?

Will the transition from Link Intime to MUFG Intime as transfer agent bring any operational improvements or cost efficiencies for Unjha Formulations?

More News on Unjha Formulations

1 Year Returns:-14.99%